Cargando…
Identification and Prioritization of Important Attributes of Disease-Modifying Drugs in Decision Making among Patients with Multiple Sclerosis: A Nominal Group Technique and Best-Worst Scaling
OBJECTIVES: Understanding the preferences of patients with multiple sclerosis (MS) for disease-modifying drugs and involving these patients in clinical decision making can improve the concordance between medical decisions and patient values and may, subsequently, improve adherence to disease-modifyi...
Autores principales: | Kremer, Ingrid E. H., Evers, Silvia M. A. A., Jongen, Peter J., van der Weijden, Trudy, van de Kolk, Ilona, Hiligsmann, Mickaël |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094791/ https://www.ncbi.nlm.nih.gov/pubmed/27812117 http://dx.doi.org/10.1371/journal.pone.0164862 |
Ejemplares similares
-
Comparison of preferences of healthcare professionals and MS patients for attributes of disease‐modifying drugs: A best‐worst scaling
por: Kremer, Ingrid E. H., et al.
Publicado: (2017) -
Nominal group technique to select attributes for discrete choice experiments: an example for drug treatment choice in osteoporosis
por: Hiligsmann, Mickael, et al.
Publicado: (2013) -
Using Best–Worst Scaling to Investigate Preferences in Health Care
por: Cheung, Kei Long, et al.
Publicado: (2016) -
Best–Worst Scaling and the Prioritization of Objects in Health: A Systematic Review
por: Hollin, Ilene L., et al.
Publicado: (2022) -
The Relative Importance of Education and Criminal Justice Costs and Benefits in Economic Evaluations: A Best–Worst Scaling Experiment
por: Pokhilenko, Irina, et al.
Publicado: (2020)